Readershipclinicians,researchers,engineers,physicians,lawyers,businessprofessionals,regulators,policymakers,andventurecapitalists PanStanfordSeriesonNanomedicineDiversity within the broad and evolving arena ofnanomedicineandnanopharmaisreflectedintheexpertiseofthedistinguishedcontributingauthors.Thechapterscontainkey words, figures in full‐color and an extensive list ofreferences. As compared to texts on the market, eachhandbookintheseriesiscomprehensiveandintendedtobeastand‐alone reference resource, presented in a user‐friendlyformat for easy access. The editors have skillfully curatedeach chapter to reflect the most relevant and currentinformationpossible.The rangeof topics coveredaswell asthemultidisciplinaryapproachofthehandbookswillattractaglobalaudience.Thehandbooksareessentialreadingforboththe novice and expert in fields ranging from medicine,biotechnology, pharmaceutical sciences, engineering, FDAlaw, intellectual property, policy, future studies, ethics,licensing,commercialization,riskanalysis,andtoxicology.HowtoOrder

SAVE20%withFREEstandardshippingwhenyouorderonlineatwww.crcpress.comandenterPromoCodePAN01

Alternatively,youcancontactourdistributorasfollows:

CRCPress(Taylor&Francis)6000BrokenSoundParkwayNW,Suite300BocaRaton,FL33487,USATel:+1800‐272‐7737Fax:+1800‐374‐3401Email:orders@taylorandfrancis.com

SeriesEditorRajBawa,MS,PhD(BawaBiotechLLC,USA,andRensselaerPolytechnicInstitute,USA) KeyFeatures Examines the entire "product wheel" from creation of

nanomedical products to final market introduction in astand‐alone,easilyaccessibleformat

Servesasanessentialreference for thenoviceandexpertalike in fields such as medicine, law, biotechnology,pharmaceutical sciences, engineering, policy, futurestudies,ethics,licensing,andtoxicology

Addresses critical topics such as personalized medicine,ethics, environmental health, nomenclature, nano‐economics, business strategy, licensing, intellectualproperty, FDA law, EPA law, and governmental policyissues

Handbook of Clinical Nanomedicine. Vol. 1. Nanoparticles,Imaging,Therapy,andClinicalApplications,RajBawa,PhD,GeraldF.Audette,PhD,andIsraelRubinstein,MD(Editors)This handbook (55 chapters) provides a comprehensiveroadmapof basic research in nanomedicine aswell as clinicalapplications. However, unlike other texts in nanomedicine, itnot only highlights current advances in diagnostics andtherapeuticsbutalsoexploresrelatedissueslikenomenclature,historical developments, regulatory aspects, nanosimilars and3D nanofabrication. While bridging the gap between basicbiomedical research, engineering, medicine and law, thehandbook provides a thorough understanding of nano’spotentialtoaddress(i)medicalproblemsfromboththepatientandhealthprovider'sperspective,and(ii)currentapplicationsandtheirpotentialinahealthcaresetting.Handbook of Clinical Nanomedicine. Vol. 2. Law, Business,Regulation,Safety,andRisk,RajBawa,PhD(Editor),GeraldF.Audette,PhD,andBrianE.Reese,PhD,MBA,JD(AssistantEditors)This unique handbook (60 chapters) examines the entire“productlifecycle,”fromthecreationofnanomedicalproductsto their final market introduction. While focusing on criticalissues relevant to nanoproduct development and translationalactivities, it tackles topics such as regulatory science, patentlaw, FDA law, ethics, personalized medicine, risk analysis,toxicology, nano‐characterization and commercializationactivities.A separate sectionprovides fascinatingperspectivesand editorials from leading experts in this complexinterdisciplinaryfield.

HandbookofClinicalNanomedicineTwo‐VolumeSet

AvailableinTwoVolumesVol.1:9789814669207(Hardcover),9789814669214(eBook)Vol.2:9789814669221(Hardcover),9789814669238(eBook)Set:9789814316170(Hardcover),9789814411660(eBook)3,000pages(approx.)January2016US$999.95/£637(IndividualvolumesareavailableseparatelyatUS$590/£376)

ReviewsforHandbookofClinicalNanomedicine:Nanoparticles,Imaging,Therapy,andClinicalApplications(Volume1)“Dr. Bawa and his team havemeticulously gathered the distilled experience ofworld‐class researchers, clinicians and businessleaders addressing the most salient issues confronted in product concept development and translation. Knowledge is power,particularly in nanomedicine translation, and this handbook is an essential guide that illustrates and clarifies our way tocommercialsuccess.”

GregoryLanza,MD,PhDProfessorofMedicineandOliverM.LangenbergDistinguishedProfessor

WashingtonUniversityMedicalSchool,USA“Thisisanoutstanding,comprehensivevolumethatcrosscutsdisciplinesandtopicsfittingindividualsfromavarietyoffieldslookingtobecomeknowledgeableinmedicalnanotechresearchanditstranslationfromthebenchtothebedside.”

ShakerA.Mousa,PhD,MBAViceProvostandProfessorofPharmacology

AlbanyCollegeofPharmacyandHealthSciences,USA“Masterful!Thishandbookwillhaveawelcomeplaceinthehandsofstudents,educators,cliniciansandexperiencedscientistsalike.Inarapidlyevolvingarena, theauthorshaveharnessed the fieldand its futurebyhighlightingbothcurrentand futureneeds indiagnosisandtherapies.Bravo!”

HowardE.Gendelman,MDMargaretR.LarsonProfessorandChair

UniversityofNebraskaMedicalCenter,USA“It isrefreshingtoseeahandbookthatdoesnotmerely focusonpreclinicalaspectsorexaggeratedprojectionsofnanomedicine.Unlikeotherbooks,thishandbooknotonlyhighlightscurrentadvancesindiagnosticsandtherapiesbutalsoaddressescriticalissuesliketerminology,regulatoryaspectsandpersonalizedmedicine.”

GertStorm,PhDProfessorofPharmaceutics

UtrechtUniversity,TheNetherlands

ReviewsforHandbookofClinicalNanomedicine:Law,Business,Regulation,Safety,andRisk(Volume2)“Thedistinguishededitorshavesecuredcontributionsfromtheleadingexpertsinnanomedicinelaw,business,regulationandpolicy.This handbook represents possibly themost comprehensive and advanced collections ofmaterials on these critical topics. Aninvaluablestandardresource.”

GregoryN.Mandel,JDPeterJ.LiacourasProfessorofLawandAssociateDean

TempleUniversityBeasleySchoolofLaw,USA“This isanoutstanding volume for those looking tobecome familiarwithnanotechnology researchand its translation from thebenchtomarket.Wayaheadofthecompetition,astandardreferenceonanyshelf.”

ShakerA.Mousa,PhD,MBAViceProvostandProfessorofPharmacology

AlbanyCollegeofPharmacy,USA“TheeditorshavegatheredthedistilledexperienceofleadersaddressingthemostsalientissuesconfrontedinR&Dandtranslation.Knowledgeispower,particularlyinnanotechnologytranslation,andthishandbookisanessentialguidethatillustratesandclarifiesourwaytocommercialsuccess.”

GregoryLanza,MD,PhDProfessorofMedicineandOliverM.LangenbergDistinguishedProfessor

WashingtonUniversityMedicalSchool,USA“The titleof thehandbook reflects itsbroad‐ranging contents.The intellectualproperty chaptersaloneareworthyof theirownhandbook.Dr.Bawaandhiscoeditorsshouldbecongratulatedforgatheringtheimportantwritingsonnanotechlaw,businessandcommercialization.”

RichardJ.Apley,JDChiefPatentOfficer

LitmanLawOffices/Becker&Poliakoff,USA“Itisclearthatthishandbookwillservetheinterdisciplinarycommunityinvolvedinnanomedicine,pharmaandbiotechinahighlycomprehensiveway.Itnotonlycoversbasicandclinicalaspectsbuttheoftenmissing,yetcriticallyimportant,topicsofsafety,risk,regulation,IPandlicensing.Thesectiontitled‘PerspectivesandEditorials’issuperb.”

Yechezkel(Chezy)Barenholz,PhDProfessorEmeritusofBiochemistryandDanielMillerProfessorofCancerResearch

HebrewUniversity‐HadassahMedicalSchool,Israel